New Delhi, September 20, 2010 Bariatric surgery, or bariatric surgery, significantly preserves kidney function and reduces kidney complications in patients with type 2 diabetes, obesity and chronic kidney disease, a study has found.

The Annals of Surgery found that patients who underwent surgery were 60 percent less likely to develop kidney disease and had a 60 percent lower risk of kidney failure and death than those who did not have surgery.

Chronic kidney disease (CKD) leads to kidney failure and is a major cause of morbidity and mortality in patients with diabetes and obesity. 40% of people with diabetes will develop chronic kidney disease in their lifetime.

Dr. Ali Armenia, director of the Obesity and Metabolism Institute at the Cleveland Clinic, said bariatric surgery can alter the course of disease in obese individuals and diabetics with chronic kidney disease. The cohort included 425 adult patients (aged 18 to 75 years) with diabetes, obesity, and stage 3 or 4 chronic kidney disease.

Of these, 183 underwent bariatric surgery and 242 received GLP-1 receptor agonists.Although the most common GLP-1 drugs were liraglutide and exenatide, 20% of patients in the nonsurgical group received newer GLP-1 drugs such as semaglutide (Ogempic) or Texanax zipatide (Monjaro).

Researchers have found that bariatric surgery is better than GLP-1 drugs in preserving kidney function and reducing patients’ risk of kidney failure or death.

People in the surgery group lost more weight and had better diabetes control.Diabetes, high blood pressure and high cholesterol are well controlled.Armenia said that despite its ability to protect the kidney, bariatric surgery remains underutilized and stressed that more research is needed to confirm this.

Sources https://in.investing.com/news/general-news/weight-loss-surgery-can-reduce-kidney-failure-risk-in-diabetics-by-44pc-study-4437665

Weight loss surgery can reduce kidney failure risk in diabetics by 44pc: Study